November 2020 FDA Recall Scandonest 3% Plain by Novocol Pharmaceutical Of Canada, Inc.
D-0127-2021 - Labeling

This Class III drug recall was voluntarily initiated by Novocol Pharmaceutical Of Canada, Inc. on November 20, 2020 for the product Scandonest 3% Plain. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0127-2021

Reason for Recall
Labeling: Label mix-up
Initiated
11-20-2020
Reported
12-16-2020
Quantity
15,398 cartridges

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Novocol Pharmaceutical of Canada, Inc.
Scandonest 3% Plain (Mepivacaine Hydrochloride 3% without Vasoconstrictor), packaged in cartons of 50 cartridges (1.7 mL each), Rx only, Manufactured for SEPTODONT, Inc., Louisville, CO 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, ON N1R 6X3, Canada, NDC 0362-1098-90

Batch or Lot Expiration Information

Batch# D03050E, D03032F, Exp 28-Feb-2022; D02983D, Exp 30-Nov-2021; D02865C, Exp 31-Aug-2021; D02894G, Exp 30-Sep-2021; D02701G, Exp 31-Jan-2021; D02766E, Exp 30-Apr-2021

Affected Packages Involved in this Recall